Biosimilars Market by IndustryARC

Biosimilars Market By Materials, By Product, By Preparation Method, By Application and By Geography Analysis - Forecast 2019 - 2024 www.industryarc.com

Biosimilars Market 2019-2024

sales@industryarc.com

Industry Market Research for Business Leaders, Strategists, Decision Makers

Press Release According to the report published by IndustryARC titled “Biosimilars Market: by Type (Recombinant Non-Glycosylated Proteins and Recombinant Glycosylated Proteins); by Technology (Recombinant DNA Technology and Monoclonal Antibody Technology); by Application (Blood Disorders, Oncology, Chronic and Autoimmune Diseases, and Others); by Geography – Forecast (2018 – 2023)”, the market is estimated to reach $27.65 billion by 2023 Browse 87 Market Tables, and 35 Figures spread through 149 Pages and go through an in-depth TOC on “Biosimilars Market” Early Buyers will receive 10% Customization on this Report. Make an inquiry @ http://www.industryarc.com/inquiry-before-buying.php?id=1262 According to a recent study from IndustryARC, the Biosimilars market is forecast to reach $27.65 billion by 2023 and is estimated to grow at a CAGR of 37%. The growth in the biosimilars market can be attributed to the low cost of biosimilars in comparison to biologics and high prevalence of life threating diseases such as cancer. The market for biosimilars is being propelled by a large number of patient’s expiration of biologics, availability of biosimilars at a lower cost, and government support and initiative in developing biosimilars. Biosimilars have slowly garnered the attention of the healthcare community as biologics have started to undergo patent expiration and they are considered as strong alternatives to biologics for the cure of life-threatening diseases. Encouragement of developing low-cost biosimilars, its approval through abbreviated regulatory frameworks, and the introduction of universal health coverage in developing economies are some of the important trends that are boosting the growth of the biosimilars market. Biosimilars are used for the treatment of certain infectious disease such as Hepatitis, blood disorders, and so on. The high incidence of chronic diseases in the western region, increased cost savings and alternative treatments offered by biosimilar products to the patients have propelled the growth of the biosimilar market. Europe was the largest market for biosimilars globally with a revenue of $xx billion in 2017. Increased spending on R&D is required to cope up with the increasing demand of biosimilars. Also, several biologics products faced patent expiration which in turn created a significant market growth in Europe. Asia-Pacific is the second largest market for biosimilars. Biosimilar uptake in countries like Japan and India is high making these countries a lucrative market for the manufacturers of biosimilars. Request for a Quote @https://industryarc.com/reports/request-quote?id=10593 The Major Players in this Market Include Novartis International AG Pfizer Inc. Biogen Inc. Celltrion Amgen Inc. Biosimilars manufacturers have utilized mergers and acquisitions as well as product launches as a strategy and enhanced core competencies through additions to product portfolio to gain a foothold in

Biosimilars Market

the emerging markets. The applications covered in the Biosimilars Market report include:

Blood Disorder Oncology Chronic and Autoimmune Diseases Growth Hormone Deficiency The overall market is also presented from the perspective of different geographic regions and the key countries for this industry. The competitive landscape for each of the application is highlighted and market players are profiled. Read More Lifesciences and Healthcare Research https://industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Reports

About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare. IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to supporting the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today. Contact Us: Mr. Venkateshwar Reddy Business Development Manager Email: sales@industryarc.com Contact Sales: 1-614-588-8538 (Ext-101) Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc

Biosimilars Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

Table of Contents 1. Biosimilars Market – Market Overview 1.1 Definitions and Scope 2. Biosimilars Market – Executive Summary 2.1 Market Revenue, Market Size and Key Trends by Company 2.2 Key trends by type 2.3 Key trends segmented by geography 3. Biosimilars Market – Industry Market Entry Scenario 3.1 Regulatory Framework Overview 3.2 New Business and Ease of Doing business index 3.3 Case studies of successful ventures 3.4 Customer Analysis – Key companies Investment 4. Biosimilars Market – Market Forces 4.1 Market Drivers 4.2 Market Constraints 4.3 Market Opportunities 4.4 Porters five force model 4.4.1 Bargaining power of suppliers 4.4.2 Bargaining powers of customers 4.4.3 Threat of new entrants 4.4.4 Rivalry among existing players 4.4.5 Threat of substitutes 5. Biosimilars Market – By Product Type (Market Size -$Million/$Billion) 5.1 Recombinant Non-Glycosylated Proteins 5.2 Recombinant Glycosylated Proteins 5.3 Peptides 6. Biosimilars Market – By Technology (Market Size -$Million/$Billion) 6.1 Monoclonal Antibodies Technology 6.2 Recombinant DNA Technology 7. Biosimilars Market – By Application (Market Size -$Million/$Billion) 7.1 Blood Disorders 7.2 Oncology Diseases 7.3 Chronic and Autoimmune Diseases 7.4 Growth Hormone Deficiency 7.5 Others 8. Biosimilars Market – By Geography (Market Size -$Million/$Billion) 8.1 North America 8.1.1 U.S 8.1.2 Canada 8.1.3 Mexico 8.2 Europe 8.2.1 UK 8.2.2 Germany 8.2.3 France 8.2.4 Italy 8.2.5 Spain 8.2.6 Russia 8.2.7 Rest of Europe 8.3 Asia-Pacific 8.3.1 China

Biosimilars Market

8.3.2 Japan 8.3.3 South Korea 8.3.4 India 8.3.5 Australia 8.3.6 Taiwan 8.3.7 Rest of APAC 8.4 Rest of the World 8.4.1 South America 8.4.2 Middle East 8.4.3 Africa 9. Biosimilars Market â&#x20AC;&#x201C; Entropy 10. Biosimilars Market â&#x20AC;&#x201C; Company Analysis 10.1 Market Share, Company Revenue, Products, M&As, Developments 10.2 Company 1 10.3 Company 2 10.4 Company 3 10.5 Company 4 10.6 Company 5 10.7 Company 6 10.8 Company 7 10.9 Company 8 10.10 Company 9 10.11 Company 10 and more "*Financials of private companies would be provided on a best-efforts basis "

Biosimilars Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

IndustryARC Solutions We cater to the pain points of our clients by providing the following solutions, which are targeted and address key issues specifically. Each of the business verticals is helpful to a client at various stages of their operational, managerial and strategic level plans. Syndicate Reports and Consulting (SRC) 1. Provide high quality analytical syndicated reports with key market insights, strategies and market forecasts for a specific industry or vertical of the clients. Constant tracking of industries and relations with experts helps us to predict and publish reports before our competitors as well as meet client needs proactively. Market Research and Data Analytics (MRDA) 2. Provide pure play data analytics services for ad-hoc and long-term engagement projects of clients with market research layered into the analysis. We are the only global company to offer this combination one-stop service to clients. Redundancies generally seen by procuring data, analytics services from multiple vendors is overcome by our solution. Competitive Landscape Analysis (CLA) 3. Provide company financial analysis, market share analysis, competitive landscape insights and market movements to clients. This is one of the most important pain point and key request from majority of our clients, for which we use our proprietary methodologies to provide accurate CLA data. Accelerated Business Development (ABD) 4. Connect clients with their customers on a global scale by acting as an outsourced sales team on behalf of the client. This is a unique tri-party engagement model to benefit the client and their customer, and acts as a business development scale up at an international level. Market Intel Reports (MIR) 5. Provide one-stop venue with a searchable syndicate reports database from global companies available to clients. This augments our offerings exponentially and also assists in studying global client needs at an in-depth level.

Biosimilars Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

About IndustryARC IndustryARC strategy studies primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

We Work for You For IndustryARC, we value every customer equally. We only stay ready to help each client in the best way possible with a unique 24x365 support plan. We suggest looking at the following benefits of relying on Professional Business Consulting and Custom Market Research Services to realize the unique strategic gains on offer: 1. 2. 3. 4. 5. 6. 7.

Strengthen and improve organizational performance Strategic planning and analysing Adoption of newer and cost-effective technologies Become environmentally sustainable and profitable Improve their training and certification procedures. Planning for business automation. Project facilitation and management.

Biosimilars Market